Core Concept Neuroscience and Psychology Published: April 29, 2026

Why Do Medicines to Treat Depression Make Some Kids Sicker?

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are among the most common medicines doctors use to treat depression and other mental health conditions. For many people, SSRIs reduce symptoms with relatively few side effects. However, unwanted effects can occur with any medication. A recently recognized side effect of SSRIs is called activation syndrome. In some children and teenagers, activation syndrome can cause symptoms such as restlessness, irritability, hyperactivity, or impulsive behavior. In rare and severe cases, it can also increase thoughts about self-harm or suicide. Researchers do not yet fully understand why activation syndrome happens in some young people. Learning more about this condition is important so doctors, families, and patients can safely use medicines that are meant to help children feel better.

What are SSRIs and Why are They Used?

Selective serotonin reuptake inhibitors (SSRIs) are a class of medicines used to treat many different mental health conditions. Most commonly, SSRIs are prescribed to treat depression [1], but they are also used to treat other conditions, including anxiety, obsessive-compulsive disorder (OCD), and panic disorder. SSRIs are the most widely used type of antidepressants. Compared to older antidepressant medicines, SSRIs have fewer side effects, and patients usually tolerate SSRIs very well, which is why doctors prescribe them more often than any other type of antidepressant [1].

Serotonin is a chemical messenger in the brain that helps send messages between brain cells called neurons. Neurons act like electrical wires, carrying and sending electrical and chemical signals throughout the brain and nervous system. Serotonin plays a role in managing sleep, digestion, and bone health, but one of its most important roles is in mood regulation. Serotonin is known as the body’s “feel-good” chemical. People tend to feel happier, calmer, more motivated, and stable when serotonin is present at normal levels. People who live with depression tend to have low amounts of serotonin, which means their moods cannot be regulated as well. Low serotonin can lead to symptoms like social withdrawal, sadness, low self-esteem, and depression.

But how does serotonin do these things? In the brain, a neuron (let us call it neuron 1) sends serotonin to a second neuron (which we will call neuron 2). Serotonin is sent through a synapse, which is the space between two neurons that allows a chemical signal to pass between them. The serotonin that is not used by neuron 2 is usually taken up back into neuron 1, with the help of a serotonin channel in the cell membrane, patiently sitting on neuron 1 waiting to do its job.

SSRIs allow more serotonin to be present in the brain by preventing serotonin from being taken back up into neuron 1 (Figure 1). Essentially, these drugs stop the channel from doing its job, which causes more serotonin to be present in the synapse between neuron 1 and neuron 2. This increased serotonin is very helpful for those who deal with depression caused by low levels of serotonin in the brain.

Diagram showing two neurons labeled neuron one and neuron two with a synapse between them, illustrating serotonin release, serotonin channels, and the action of selective serotonin reuptake inhibitors (SSRIs) blocking serotonin reuptake.
  • Figure 1 - The mechanism of SSRIs in the brain.
  • Neurons can communicate by sending and receiving serotonin. Normally, neuron 1 sends serotonin to neuron 2. Any extra serotonin is taken back up into neuron 1, preventing any leftover serotonin from being taken back into that cell. This allows more serotonin to be available in the synapse, which can help people with depression caused by low amounts of serotonin in the brain. Source: Google. (2025). Gemini (2.0 Flash) [Google AI Plus, Nano Banana 2.0] [1].

Activation Syndrome in Young People Taking SSRIs

Researchers have studied how SSRIs affect the brain for several decades (Figure 2). However, more research is needed to understand how this medicine can affect children and adolescents. Specifically, physicians and researchers have identified some extreme side effects that children and adolescents can experience from taking certain antidepressants and other medications to treat mental health conditions. They call these rare side effects activation syndrome.

Side-by-side diagrams compare healthy serotonin signaling versus activation syndrome under SSRI treatment, showing neuron responses and serotonin reuptake, with bullet point lists summarizing healthy outcomes and activation syndrome symptoms such as anxiety, mood changes, and aggression.
  • Figure 2 - In most individuals who take SSRIs, the extra serotonin in the synapse is helpful for their symptoms and does not cause any negative side effects.
  • These individuals will likely experience the benefits of SSRIs listed in green below the image. In people who experience activation syndrome, more serotonin (gold dots) is produced, so more of it sticks to and is absorbed by neuron 2, overstimulating the cell. The symptoms of activation syndrome are listed below the image, in red. Source: Google. (2025). Gemini (2.0 Flash) [Google AI Plus, Nano Banana 2.0]. Adapted from “Electrical Synapses v. Chemical Synapses”, by BioRender.com (2024).

What is activation syndrome? Imagine you take an antidepressant medication prescribed by your doctor so that you can feel less depressed and anxious and more motivated and content. However, after taking this medication, you start to feel worse than you did before. Maybe you feel irritable, restless, hyperactive, or impulsive [2, 3]. In extreme cases, children and teenagers can experience increased thoughts about and risk of suicide. Because the list of symptoms kids with activation syndrome can experience is very long, doctors still struggle to define and identify this dangerous side effect. It is also difficult for doctors to diagnose because the range and intensity of symptoms can vary between individuals. Additionally, sometimes the symptoms of activation syndrome are difficult to tell apart from the symptoms of the child’s original mental health condition [24]. Unfortunately, treating activation syndrome is not as easy as stopping the medication. If someone abruptly stops taking SSRIs, they can experience dangerous withdrawal symptoms that are physical (dizziness, headache, muscle aches, nausea, etc.), chemical (“brain zaps”, tingling, burning), or emotional (anxiety, agitation, mood swings, etc.). Doctors have to carefully adjust the dose or slowly reduce the medication while monitoring children and adolescents.

There are several theories that could explain why children and adolescents might experience extreme, rare side effects from SSRIs. One common theory suggests that these young individuals could have more serotonin activity than normal in a part of the brain called the frontal cortex [2]. For example, in some kids who are around the age of puberty, the neurons in this brain region might release more serotonin than usual [2, 3]. When these kids take SSRIs, and the channels that allow neurons to take back extra serotonin are blocked, the high levels of serotonin floating around in the synapses may “overstimulate” neuron 2, leading to the symptoms of activation syndrome (Figure 2). Although this theory is still unproven and the cause of activation syndrome remains a mystery, blocking the effects of serotonin on neurons seemed to improve the extreme side effects [4].

Why is Activation Syndrome Less Concerning in Adults?

Compared to children and teenagers, adult brains are fully developed. Certain areas in the brains of children and teenagers, important for learning and behavior, are still growing. For example, the frontal lobe is critical for planning, decision making, and movement; and the hippocampus and amygdala are essential for memory and emotional processing. These brain areas can be negatively impacted by factors inside and outside the body, including medications or lifestyle activities like school, work, social groups, and social media [5]. While researchers still do not know for sure, children and teenagers may be more likely to experience problems from medication because these brain areas are still developing [4]. When three critical brain regions are not working properly as they should be, this can cause a child or teenager to experience a wide range of side effects (Figure 3).

Illustration of a brain in sagittal view labeling the frontal lobe, amygdala, and hippocampus with their functions; adjacent icons depict five common symptoms: extreme fatigue, aggression, emotional irritability, emotional dysregulation, and hyper-arousal, each with expressive cartoon faces.
  • Figure 3 - Here you can see a sideways view of the brain, as if it were cut down the center.
  • The frontal lobe, amygdala, and hippocampus are shown. Common symptoms of activation syndrome, shown on the right, may result from the complex relationship between these three brain regions in response to SSRI medications. Source: Google. (2025). Gemini (2.0 Flash) [Google AI Plus, Nana Banana 2.0]. Adapted from “The Limbic System”, by BioRender.com (2024).

Questions about how and why SSRIs result in dangerous side effects like activation syndrome can be investigated by studying a young individual’s medical history, prior risk factors from family or social history, or environmental cues. For example, changes in hormones or exposure to smoking and unhealthy environments can make a growing child more vulnerable to experiencing side effects. Some children and adolescents do not respond to SSRI medications because of these factors [2, 4]. Children under the age of 13 are more sensitive than older children are to changes in the brain following an extreme side effect. Children can be more susceptible to mental health conditions based on how old they were at the time an adverse event occurred. Age is a key factor used by physicians to figure out how early a problem starts and potentially why. In addition, just getting older and more mature often helps reduce extreme side effects and causes these problems to go away on their own.

To safely prescribe SSRI medicines to children and adolescents, doctors must consider many factors. First, they must make sure the diagnosis of the mental health condition is correct. Different conditions need different medicines to treat them. Effective medication management requires doctors to tailor treatment based on a child’s age, the specific drug, drug duration, timing of the dose, and specific factors that match the individual’s symptoms [4]. By prioritizing these factors, healthcare providers ensure patient-centered care for children, adolescents, and adults receiving SSRIs or other psychiatric medications. Fully understanding a patient’s mental and physical health can help doctors make sure they are prescribing the right medication in the right amount—and will also help them understand when they need to stop a particular medication and how to do so.

Glossary

Selective Serotonin Reuptake Inhibitors (SSRIs): A class of antidepressant medicines that increase serotonin levels in the brain by preventing serotonin from being taken back into neurons.

Mental Health Conditions: Conditions involving changes in emotion, thinking, or behavior (or combination of these).

Antidepressant: A type of medicine used to treat depression and several other mental health conditions.

Side Effect: A secondary or undesirable effect of a drug or medical treatment.

Serotonin: A chemical messenger in the brain that helps regulate mood, sleep, and other body functions.

Neurons: Cells that make up the brain and nervous system.

Synapse: Space between neurons that serves as a relay station for communication between the two cells.

Activation Syndrome: A group of symptoms, such as restlessness or hyperactivity, that can sometimes occur after starting certain antidepressant medications.

Conflict of Interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

AI Tool Statement

The author(s) declared that generative AI was used in the creation of this manuscript. We used Gemini 3 Flash (Model: Nano Banana 2, Web version) to generate the conceptual diagrams presented in all 3 figures of this manuscript as well as editing, revisions, changes, or feedback on the figures.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.


References

[1] Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., et al. 2021. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol. Int. 13:387–401. doi: 10.3390/neurolint13030038

[2] Amitai, M., Chen, A., Weizman, A., and Apter, A. 2015. SSRI-induced activation syndrome in children and adolescents—what is next? Curr. Treat. Options Psychiatry 2:28–37. doi: 10.1007/s40501-015-0034-9

[3] Sinclair, L. I., Christmas, D. M., Hood, S. D., Potokar, J. P., Robertson, A., Isaac, A., et al. 2009. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br. J. Psychiatry 194:483–90. doi: 10.1192/bjp.bp.107.048371

[4] Luft, M. J., Lamy, M., DelBello, M. P., McNamara, R. K., and Strawn, J. R. 2018. Antidepressant-induced activation in children and adolescents: risk, recognition and management. Curr. Prob. Pediatr. Adolesc. Health Care 48:50–62. doi: 10.1016/j.cppeds.2017.12.001

[5] Reid, J. M., Storch, E. A., Murphy, T. K., Bodzin, D., Mutch, P. J., Lehmkuhl, H., et al. (2010). Development and psychometric evaluation of the treatment-emergent activation and suicidality assessment profile. Child Youth Care Forum 39:113–24. doi: 10.1007/s10566-010-9095-5